THRD

Third Harmonic Bio, Inc. · NASDAQ

Performance

+1.37%

1W

-16.07%

1M

+1.86%

3M

-11.4%

6M

+14.77%

YTD

+27.43%

1Y

Profile

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Technical Analysis of THRD 2024-12-09

The stock's indicators reflect a neutral sentiment, with the Moving Average Score at 43, Oscillators Score at 46, and a Technical Score of 45, suggesting a lack of strong bullish or bearish momentum in the market. Overall, these scores indicate that the stock is currently in a consolidation phase, warranting cautious observation for potential fu...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of THRD

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.